ARCHIVES

DCT Board Approves Recommendations For Clinical Trials; Some Controversial

This article is from The Cancer Letter archive.

Vol. 05 No. 45 | November 9, 1979

Download PDF Visit The Full Archive

Related Articles

NCI Releases 550 Pages of Internal Documents Related To Duke Scandal

January 7, 2011

Judge Declines To Issue Injunction To Stop Amgen’s “Bundling.”

December 1, 2006

FDA: Oncology Division Director Delap Promoted In Agency

May 29, 1998

New Protocol Could Improve Survival Of Rare Brain Tumor

October 30, 2009

Committee Holds Up RFP For Frederick, Asks Six Month Delay

September 24, 1976

A Patchwork Of Policies Emerges As Insurers Tighten Payments For ESAs.

March 30, 2007